Objectives: Neurocardiogenic syncope is a common and challenging problem in clinical practice. Heart rate recovery after the first minute of exercise is mainly controlled by the parasympathetic nervous system. The aim of the present study was to evaluate heart rate recovery as an index of parasympathetic tonus for the diagnosis of neurocardiogenic syncope. Methods and Results: Ninety five patients (mean age 36.5 ± 11.8 years), who had vasovagal syncope episodes documented by tilt table testing and 70 healthy subjects (mean age 32.9 ± 9.1 years) were included in this study. Maximal exercise stress testing was performed in both groups and heart rate recovery values were calculated. Heart rate recovery was calculated by subtracting recovery heart rate in the first minute after exercise from peak heart rate. Heart rate recovery was significantly higher in the vasovagal syncope group than the control group during the first minute (42.1 vs. 30.9, p < 0.001). When the cutoff point for heart rate recovery was taken as 35, the sensitivity for the diagnosis of vasovagal syncope was 81% and the specificity was 78%. Conclusion: Results of our study show that heart rate recovery is greater in the first minute after exercise in vasovagal syncope patients and that it has a supportive role in the diagnosis of neurocardiogenic syncope.

Keywords:
Neurocardiogenic syncope, Heart rate recovery index, Tilt table test
1.
Savage DD, Corwin L, McGee DL, Kannel WB, Wolf PA: Epidemiologic features of isolated syncope: The Framingham study. Stroke 1985;16:626–629.
2.
Fitzpatrick A, Sutton R: Tilting towards a diagnosis in recurrent unexplained syncope. Lancet 1989;1:658–660.
3.
Benditt DG, Ferguson DW, Grubb BP, Kapoor WN, Kugler J, Lerman BB, Maloney JD, Raviele A, Ross B, Sutton R, Wolk MJ, Wood DL: Tilt table testing for assessing syncope. American college of cardiology. J Am Coll Cardiol 1996;28:263–275.
4.
Kenny RA, Ingram A, Bayliss J, Sutton R: Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1986;1:1352–1355.
5.
Abi-Samra F, Maloney JD, Fouad-Tarazi FM, Castle LW: The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin. Pacing Clin Electrophysiol 1988;11:1202–1214.
6.
Benditt DG, Remole S, Bailin S, Dunnigan A, Asso A, Milstein S: Tilt table testing for evaluation of neurally-mediated (cardioneurogenic) syncope: rationale and proposed protocols. Pacing Clin Electrophysiol 1991;14:1528–1537.
7.
Pierpont GL, Stolpman DR, Gornick CC: Heart rate recovery post-exercise as an index of parasympathetic activity. J Auton Nerv Syst 2000;80:169–174.
8.
Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Masotti G, Moya A, Raviele A, Sutton R, Theodorakis G, Ungar A, Wieling W: Guidelines on management (diagnosis and treatment) of syncope: update 2004. Europace 2004;6:467–537.
9.
Julu PO, Cooper VL, Hansen S, Hainsworth R: Cardiovascular regulation in the period preceding vasovagal syncope in conscious humans. J Physiol 2003;549:299–311.
10.
Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R: Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991;17:125–130.
11.
Stein KM, Slotwiner DJ, Mittal S, Scheiner M, Markowitz SM, Lerman BB: Formal analysis of the optimal duration of tilt testing for the diagnosis of neurally mediated syncope. Am Heart J 2001;141:282–288.
12.
Baron-Esquivias G, Pedrote A, Cayuela A, Valle JI, Fernandez JM, Estepa MJ, Martinez-Morentin E, Navarro M, Burgos J: Age and gender differences in basal and isoprenaline protocols for head-up tilt table testing. Europace 2001;3:136–140.
13.
Almquist A, Goldenberg IF, Milstein S, Chen MY, Chen XC, Hansen R, Gornick CC, Benditt DG: Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989;320:346–351.
14.
Kapoor WN: Evaluation and management of the patient with syncope. JAMA 1992;268:2553–2560.
15.
Morillo CA, Klein GJ, Zandri S, Yee R: Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J 1995;129:901–906.
16.
Carlioz R, Graux P, Haye J, Letourneau T, Guyomar Y, Hubert E, Bodart JC, Lequeuche B, Burlaton JP: Prospective evaluation of high-dose or low-dose isoproterenol upright tilt protocol for unexplained syncope in young adults. Am Heart J 1997;133:346–352.
17.
Raviele A, Menozzi C, Brignole M, Gasparini G, Alboni P, Musso G, Lolli G, Oddone D, Dinelli M, Mureddu R: Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995;76:267–272.
18.
Bartoletti A, Alboni P, Ammirati F, Brignole M, Del Rosso A, Foglia Manzillo G, Menozzi C, Raviele A, Sutton R: ‘The Italian protocol’: a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. Europace 2000;2:339–342.
19.
Sheldon R, Splawinski J, Killam S: Reproducibility of isoproterenol tilt-table tests in patients with syncope. Am J Cardiol 1992;69:1300–1305.
20.
Grubb BP, Wolfe D, Temesy-Armos P, Hahn H, Elliott L: Reproducibility of head upright tilt table test results in patients with syncope. Pacing Clin Electrophysiol 1992;15:1477–1481.
21.
de Buitleir M, Grogan EW Jr, Picone MF, Casteen JA: Immediate reproducibility of the tilt-table test in adults with unexplained syncope. Am J Cardiol 1993;71:304–307.
22.
Brooks R, Ruskin JN, Powell AC, Newell J, Garan H, McGovern BA: Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol 1993;71:1289–1292.
23.
Yawn BP, Ammar KA, Thomas R, Wollan PC: Test-retest reproducibility of heart rate recovery after treadmill exercise. Ann Fam Med 2003;1:236–241.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.